SEC Form 4 · accession 0001246360-17-002022
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel A Giannini
Director
Period of report
May 25, 2017
Accepted (ET)
May 26, 2017 · 3:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $22.78 | May 25, 2017 | A | 15,643 | A | Jun 25, 2017 | May 24, 2024 | Common Stock | 15,643 | 15,643 | D |
Explanation of responses
- F1The stock option becomes exercisable in 12 equal monthly installments beginning June 25, 2017.